5-lipoxygenase-activating protein (FLAP) inhibitors

Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HUTCHINSON JOHN H, PRASIT PETPIBOON PEPPI, STOCK NICHOLAS SIMON, EVANS JILLIAN F, HADDACH MUSTAPHA, STEARNS BRIAN ANDREW, MORAN MARK, ZUNIC JASMINE ELEANOR, ROPPE JEFFREY ROGER, LI YIWEI, ARRUDA JEANNIE M
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HUTCHINSON JOHN H
PRASIT PETPIBOON PEPPI
STOCK NICHOLAS SIMON
EVANS JILLIAN F
HADDACH MUSTAPHA
STEARNS BRIAN ANDREW
MORAN MARK
ZUNIC JASMINE ELEANOR
ROPPE JEFFREY ROGER
LI YIWEI
ARRUDA JEANNIE M
description Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US8399666B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US8399666B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US8399666B23</originalsourceid><addsrcrecordid>eNrjZDA21c3JLMivqExPzUssTtVNTC7JLEssycxLVygoyi9JzcxT0HDzcQzQVMjMy8hMyizJLyrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxocEWxpaWZmZmTkbGRCgBAIbHK-s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>5-lipoxygenase-activating protein (FLAP) inhibitors</title><source>esp@cenet</source><creator>HUTCHINSON JOHN H ; PRASIT PETPIBOON PEPPI ; STOCK NICHOLAS SIMON ; EVANS JILLIAN F ; HADDACH MUSTAPHA ; STEARNS BRIAN ANDREW ; MORAN MARK ; ZUNIC JASMINE ELEANOR ; ROPPE JEFFREY ROGER ; LI YIWEI ; ARRUDA JEANNIE M</creator><creatorcontrib>HUTCHINSON JOHN H ; PRASIT PETPIBOON PEPPI ; STOCK NICHOLAS SIMON ; EVANS JILLIAN F ; HADDACH MUSTAPHA ; STEARNS BRIAN ANDREW ; MORAN MARK ; ZUNIC JASMINE ELEANOR ; ROPPE JEFFREY ROGER ; LI YIWEI ; ARRUDA JEANNIE M</creatorcontrib><description>Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130319&amp;DB=EPODOC&amp;CC=US&amp;NR=8399666B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130319&amp;DB=EPODOC&amp;CC=US&amp;NR=8399666B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HUTCHINSON JOHN H</creatorcontrib><creatorcontrib>PRASIT PETPIBOON PEPPI</creatorcontrib><creatorcontrib>STOCK NICHOLAS SIMON</creatorcontrib><creatorcontrib>EVANS JILLIAN F</creatorcontrib><creatorcontrib>HADDACH MUSTAPHA</creatorcontrib><creatorcontrib>STEARNS BRIAN ANDREW</creatorcontrib><creatorcontrib>MORAN MARK</creatorcontrib><creatorcontrib>ZUNIC JASMINE ELEANOR</creatorcontrib><creatorcontrib>ROPPE JEFFREY ROGER</creatorcontrib><creatorcontrib>LI YIWEI</creatorcontrib><creatorcontrib>ARRUDA JEANNIE M</creatorcontrib><title>5-lipoxygenase-activating protein (FLAP) inhibitors</title><description>Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDA21c3JLMivqExPzUssTtVNTC7JLEssycxLVygoyi9JzcxT0HDzcQzQVMjMy8hMyizJLyrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxocEWxpaWZmZmTkbGRCgBAIbHK-s</recordid><startdate>20130319</startdate><enddate>20130319</enddate><creator>HUTCHINSON JOHN H</creator><creator>PRASIT PETPIBOON PEPPI</creator><creator>STOCK NICHOLAS SIMON</creator><creator>EVANS JILLIAN F</creator><creator>HADDACH MUSTAPHA</creator><creator>STEARNS BRIAN ANDREW</creator><creator>MORAN MARK</creator><creator>ZUNIC JASMINE ELEANOR</creator><creator>ROPPE JEFFREY ROGER</creator><creator>LI YIWEI</creator><creator>ARRUDA JEANNIE M</creator><scope>EVB</scope></search><sort><creationdate>20130319</creationdate><title>5-lipoxygenase-activating protein (FLAP) inhibitors</title><author>HUTCHINSON JOHN H ; PRASIT PETPIBOON PEPPI ; STOCK NICHOLAS SIMON ; EVANS JILLIAN F ; HADDACH MUSTAPHA ; STEARNS BRIAN ANDREW ; MORAN MARK ; ZUNIC JASMINE ELEANOR ; ROPPE JEFFREY ROGER ; LI YIWEI ; ARRUDA JEANNIE M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US8399666B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HUTCHINSON JOHN H</creatorcontrib><creatorcontrib>PRASIT PETPIBOON PEPPI</creatorcontrib><creatorcontrib>STOCK NICHOLAS SIMON</creatorcontrib><creatorcontrib>EVANS JILLIAN F</creatorcontrib><creatorcontrib>HADDACH MUSTAPHA</creatorcontrib><creatorcontrib>STEARNS BRIAN ANDREW</creatorcontrib><creatorcontrib>MORAN MARK</creatorcontrib><creatorcontrib>ZUNIC JASMINE ELEANOR</creatorcontrib><creatorcontrib>ROPPE JEFFREY ROGER</creatorcontrib><creatorcontrib>LI YIWEI</creatorcontrib><creatorcontrib>ARRUDA JEANNIE M</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HUTCHINSON JOHN H</au><au>PRASIT PETPIBOON PEPPI</au><au>STOCK NICHOLAS SIMON</au><au>EVANS JILLIAN F</au><au>HADDACH MUSTAPHA</au><au>STEARNS BRIAN ANDREW</au><au>MORAN MARK</au><au>ZUNIC JASMINE ELEANOR</au><au>ROPPE JEFFREY ROGER</au><au>LI YIWEI</au><au>ARRUDA JEANNIE M</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>5-lipoxygenase-activating protein (FLAP) inhibitors</title><date>2013-03-19</date><risdate>2013</risdate><abstract>Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US8399666B2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title 5-lipoxygenase-activating protein (FLAP) inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T03%3A03%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HUTCHINSON%20JOHN%20H&rft.date=2013-03-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS8399666B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true